Hims & Hers announced that its board of directors has authorized a share repurchase program of up to $250M of outstanding Class A common stock over the next three years. This new program follows the successful completion of the company’s prior $100M share repurchase program, established in July 2024, which has now been fully utilized.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIMS:
- Hims & Hers names Deb Autor as Chief Policy Officer
- Sell Rating on Hims & Hers Health Due to Overvaluation and Growth Concerns
- Hims & Hers Stock (HIMS) Plunges despite New ‘Affordable’ Healthcare Platform
- Mixed options sentiment in Hims and Hers Health with shares down 6.37%
- Hims & Hers launches Labs in-depth testing experience